COPENHAGEN (Reuters) - Novo Nordisk said on Friday the results from a trial showed that its Victoza diabetes drug significantly reduced the risks of major adverse cardiovascular events.
http://ift.tt/24FE1Qg
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire